Rallybio CorporationRLYBNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-24.8%
5Y CAGR+2.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-24.8%/yr
Annual compound
5Y CAGR
+2.6%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $28.83M | -52.8% |
| 2024 | $61.13M | -22.6% |
| 2023 | $78.93M | +16.3% |
| 2022 | $67.88M | +48.7% |
| 2021 | $45.65M | +80.4% |
| 2020 | $25.30M | +43.4% |
| 2019 | $17.64M | - |